Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve Cannabis Corp. has opened a new dispensary in Palm Harbor, Florida, marking its 64th nationwide location. The new nearly 2,750 sq. ft. facility aims to enhance patient access to a diverse range of medical cannabis products in Pinellas County. This launch follows a significant increase in patient registrations, with about 90,000 new patients in the last six months, highlighting the growing demand. On opening day, all patients will receive a 25% discount. Trulieve continues to expand its footprint in Florida, where it consistently captures approximately half of the state's cannabis sales.
Summary not available.
Trulieve Cannabis Corp. has opened its 60th dispensary in Florida, located in Merritt Island, marking a significant expansion. The new 6,500 sq. ft. store aims to enhance patient access to medical cannabis for the growing number of registered patients, which has increased by approximately 90,000 in the past six months. All patients can enjoy a 25% discount on opening day. Trulieve continues to lead the Florida cannabis market, responsible for about half of the state's medical marijuana sales, with a total of nearly 425,000 registered patients and over 2,600 participating physicians.
Trulieve Cannabis Corp. announces CEO Kim Rivers will participate in two significant upcoming virtual conferences. On September 29, 2020, she will engage in the Alliance Global Partners Consumer Cannabis Virtual Conference, allowing one-on-one meetings with industry leaders. Additionally, on September 30, 2020, she will deliver a live presentation at Canaccord Genuity's Virtual US Cannabis Symposium at 9:00 a.m. EST. Trulieve is a top-performing cannabis company based in Florida and operates across several states, including California and Massachusetts.
Summary not available.
Trulieve Cannabis Corp. announced strategic acquisitions of PurePenn LLC and Solevo Wellness to enhance its presence in Pennsylvania, expanding its multi-state footprint. The transactions, valued at $46 million for PurePenn and $20 million for Solevo, will boost Trulieve's cultivation capabilities by adding 35,000 square feet of existing facilities, with plans for expansion. This move aims to solidify Trulieve's position in the rapidly growing Pennsylvania cannabis market, projected to reach $575 million by 2020. The acquisitions are expected to close in Q4 2020, contingent on regulatory approvals.
Trulieve Cannabis Corp. (OTCQX: TCNNF) opened its 60th dispensary nationwide and 58th in Florida, located in Tampa, on September 11, 2020. This new location aims to enhance patient access to medical cannabis in Hillsborough County, joining two other dispensaries in the Tampa area. To celebrate, a 25% discount is offered on opening day. Trulieve supports over 410,000 registered medical marijuana patients in Florida, serving nearly half of the state's overall volume. Customers can access a wide range of THC and CBD products, with options for online ordering, curbside pickup, and home delivery.
Trulieve Cannabis Corp. announced that CEO Kim Rivers will participate in virtual conferences: the 9th Annual Gateway Conference on September 9, 2020, and the Beacon Securities Cannabis Conference on September 10, 2020. Rivers will engage in a fireside chat at 1:00 p.m. EST and deliver a presentation at 2:00 p.m. EST, respectively. Both events will be webcast live and available for replay. Trulieve, a leading medical cannabis company based in Florida, is listed on the OTCQX under the symbol TCNNF.
Trulieve Cannabis Corp (OTCQX: TCNNF) made history in Florida by recording its first sale of edible cannabis, TruChocolate, on September 5, 2020, shortly after receiving state approval. This marks Trulieve's continued leadership in the cannabis market, offering a range of edible products including those from partner brand Love’s Oven. The company aims to enhance access to medication for Florida patients and has plans for broader distribution across its stores, showcasing a commitment to innovation and customer service.
Trulieve Cannabis Corp (OTCQX: TCNNF) has launched its first line of edible cannabis products in Florida, following approval from the Department of Health. This historic rollout took place at the Tallahassee dispensary, marking the first edible sale in the state. The company aims to enhance patient access to preferred medication formats, responding to years of demand. Initial offerings include TruGel in blue raspberry, with plans for additional flavors and collaborations with specialty brands. This move signifies a significant expansion in Trulieve's product offerings.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
